Држава: Јапан
Језик: Енглески
Извор: すりの適正使用協議会 RAD-AR Council, Japan
Ibandronate sodium hydrate
Taisho Pharmaceutical Co., Ltd.
Ibandronate sodium hydrate
injection
Drug Information Sheet("Kusuri-no-Shiori") Injection Revised: 04/2023 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: BONVIVA SYRINGES FOR INTRAVENOUS INJECTION 1MG ACTIVE INGREDIENT: Ibandronate sodium hydrate DOSAGE FORM: injection IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine suppresses bone resorption by osteoclasts in the bone, thereby increasing bone density and preventing bone fractures. It is usually used to treat osteoporosis. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have hypocalcemia or renal disorder. ・If you are pregnant, possibly pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, inject intravenously once a month. ・The treatment period with this medicine depends on your response to the treatment. PRECAUTIONS WHILE TAKING THIS MEDICINE ・If you become pregnant or may have become pregnant while using this medicine, consult with your doctor or pharmacist immediately. ・Try to take enough calcium and vitamin D through meals, etc. ・Abnormalities in the jaw bone may occur while using bisphosphonates, including this medicine. S Прочитајте комплетан документ